Replimune Group, Inc. REPL
Set alert
19.83 USD +0.34 +1.72%
As of Nov 3, 12:28 PM ET
19.50 Day range 21.26
1.50 52-week range 21.26
- YTD
- +103.96%
- 1 year
- +112.94%
- Open
- 19.52
- Prev close
- 19.49
- Mkt cap
- 1.88B
- Vol
- 2.42M
- Avg vol
- 2.95M
- EPS
- -2.79
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 19.50
- High
- 21.26
- Forward P/E
- -29.05
- Beta
- 0.93
- Short ratio
- 11.50
- Inst. own
- 105.25%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 2, 2027
- 50-d avg
- 13.58
- 200-d avg
- 9.29
- 1y target
- 23.33
5D chart
Events in this range
- Oct 28, 2026Earnings: -0.54; estimate -0.784; surprise 31.12%
- Oct 29, 2026Rating: Leerink Partners · Outperform → Outperform
Signals (96)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 3, 11:15 AM | 1 hour ago |
| SMA: Bearish | Nov 3, 10:50 AM | 1 hour ago |
| MACD: Sell Signal | Nov 3, 10:30 AM | 2 hours ago |
| SMA: Bullish | Nov 3, 10:10 AM | 2 hours ago |
| SMA: Bearish | Nov 3, 9:55 AM | 2 hours ago |
| RSI: Overbought | Nov 3, 9:30 AM | 3 hours ago |
| RSI: Overbought | Nov 2, 3:40 PM | 20 hours ago |
| RSI: Overbought | Nov 2, 3:30 PM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 3:15 PM | 21 hours ago |
| RSI: Overbought | Nov 2, 3:15 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 2:45 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 22 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 22 hours ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 22 hours ago |
| RSI: Overbought | Nov 2, 1:10 PM | 23 hours ago |
| MACD: Buy Signal | Nov 2, 12:25 PM | 1 day ago |
| SMA: Bullish | Nov 2, 12:10 PM | 1 day ago |
| SMA: Bullish | Nov 2, 12:05 PM | 1 day ago |
| SMA: Bearish | Nov 2, 12:00 PM | 1 day ago |
Newest 20 of 96.
Analyst view
Consensus: buy
Buy
Price target (mean) 23.33 +17.7% upside
Now 19.83
- Target (low)
- 14.00
- Target (mean)
- 23.33
- Target (high)
- 31.00
Ratings (0m) 8 7 buy · 0 hold · 1 sell
- Strong buy2
- Buy5
- Hold0
- Sell1
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.47035 | -0.4914 – -0.45 | -0.77 | +38.9% | 7.19M | 0.0% | 4 |
| Next quarter | -0.38767 | -0.423 – -0.33 | -0.76 | +49.0% | 16.43M | 0.0% | 3 |
| Current year | -2.01 | -2.01 – -2.01 | -3.38 | +40.5% | 34.83M | 0.0% | 1 |
| Next year | -0.67084 | -1.16 – 0.43 | -2.01 | +66.6% | 195.55M | +461.4% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Aug 26, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 7, 2026 | Wedbush | Upgrade | Neutral | Outperform |
| Aug 4, 2026 | Leerink Partners | Upgrade | Market Perform | Outperform |
| Jul 31, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Jul 31, 2026 | Cantor Fitzgerald | Upgrade | Neutral | Overweight |
| Jun 30, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Jun 26, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| Jun 1, 2026 | Wedbush | Maintained | Neutral | Neutral |
| May 29, 2026 | JP Morgan | Upgrade | Underweight | Neutral |
| Apr 13, 2026 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Apr 13, 2026 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Apr 13, 2026 | JP Morgan | Downgrade | Neutral | Underweight |
| Apr 13, 2026 | Wedbush | Downgrade | Outperform | Neutral |
| Apr 13, 2026 | Jefferies | Downgrade | Buy | Hold |
| Apr 13, 2026 | HC Wainwright & Co. | Downgrade | Buy | Sell |
| Feb 5, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 4, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Nov 3, 2025 | BMO Capital | Upgrade | Underperform | Market Perform |
| Oct 27, 2025 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Oct 20, 2025 | JP Morgan | Upgrade | Underweight | Neutral |
| Oct 20, 2025 | Leerink Partners | Upgrade | Market Perform | Outperform |
| Oct 20, 2025 | Wedbush | Upgrade | Neutral | Outperform |
| Sep 19, 2025 | JP Morgan | Downgrade | Neutral | Underweight |
| Sep 8, 2025 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Jul 30, 2025 | Cantor Fitzgerald | Upgrade | Neutral | Overweight |
| Jul 23, 2025 | BMO Capital | Downgrade | Outperform | Underperform |
| Jul 23, 2025 | Barclays | Downgrade | Overweight | Equal-Weight |
| Jul 23, 2025 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
